[go: up one dir, main page]

MX2018008519A - Composiciones que comprenden vitaminas y su uso. - Google Patents

Composiciones que comprenden vitaminas y su uso.

Info

Publication number
MX2018008519A
MX2018008519A MX2018008519A MX2018008519A MX2018008519A MX 2018008519 A MX2018008519 A MX 2018008519A MX 2018008519 A MX2018008519 A MX 2018008519A MX 2018008519 A MX2018008519 A MX 2018008519A MX 2018008519 A MX2018008519 A MX 2018008519A
Authority
MX
Mexico
Prior art keywords
potential
compositions
composition
include vitamins
female subject
Prior art date
Application number
MX2018008519A
Other languages
English (en)
Inventor
Schneider Nora
HAUSER Jonas
DEONI Sean
Bartfai Tamas
Silva Zolezzi Irma
Mary Samuel Tinu
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2018008519A publication Critical patent/MX2018008519A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición que comprende al menos una vitamina, para usar en la promoción, apoyo u optimización de uno o más de los siguientes: (i) mielinización de novo; (ii) estructura del cerebro; (iii) conectividad del cerebro; (iv) potencial intelectual; (v) potencial cognitivo; (vi) potencial de aprendizaje; y (vii) funcionamiento cognitivo en una cría de un sujeto femenino, en donde dicha composición es para la administración al sujeto femenino.
MX2018008519A 2016-03-30 2016-12-13 Composiciones que comprenden vitaminas y su uso. MX2018008519A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662315158P 2016-03-30 2016-03-30
US201662315163P 2016-03-30 2016-03-30
US201662315142P 2016-03-30 2016-03-30
US201662315134P 2016-03-30 2016-03-30
US201662315152P 2016-03-30 2016-03-30
US201662328119P 2016-04-27 2016-04-27
PCT/EP2016/080796 WO2017167420A1 (en) 2016-03-30 2016-12-13 Compositions comprising vitamins and their use

Publications (1)

Publication Number Publication Date
MX2018008519A true MX2018008519A (es) 2018-08-16

Family

ID=57614348

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2018008519A MX2018008519A (es) 2016-03-30 2016-12-13 Composiciones que comprenden vitaminas y su uso.
MX2018011334A MX2018011334A (es) 2016-03-30 2017-03-30 Composiciones y su uso.
MX2022014682A MX2022014682A (es) 2016-03-30 2018-09-18 Composiciones y su uso.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2018011334A MX2018011334A (es) 2016-03-30 2017-03-30 Composiciones y su uso.
MX2022014682A MX2022014682A (es) 2016-03-30 2018-09-18 Composiciones y su uso.

Country Status (8)

Country Link
EP (2) EP3436015A2 (es)
CN (4) CN108367009A (es)
BR (2) BR112018011404A2 (es)
CA (3) CA3004046A1 (es)
MX (3) MX2018008519A (es)
PH (1) PH12018501830A1 (es)
SG (2) SG11201803025VA (es)
WO (1) WO2017167420A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110157711B (zh) * 2019-02-01 2023-10-24 大连大学 一种人的srebp1基因编码区全长分段克隆的方法
AU2021317083A1 (en) * 2020-07-27 2023-03-02 George AYOUB Methods of reducing incidence or risk of cerebral folate deficiency
IT202100022427A1 (it) * 2021-08-27 2023-02-27 Buona S P A Soc Benefit Composizione per la maturazione del sistema nervoso centrale
EP4572618A1 (en) 2022-08-18 2025-06-25 Société des Produits Nestlé S.A. Kit to promote developmental myelination
CN116195643A (zh) * 2022-12-20 2023-06-02 安徽九鑫药业有限公司 一种补脑的核桃油乳粉制剂
WO2025143715A1 (ko) * 2023-12-26 2025-07-03 주식회사 비케이바이오 인지질 혼합물, 중성지질 및 스핀고리피드를 포함하는 인지기능 개선 조성물
WO2025252789A1 (en) 2024-06-04 2025-12-11 Société des Produits Nestlé S.A. Nutritional composition linked to brain myelination, brain structure, cognition and learning in typically developing school age children

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322589B1 (fr) 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
WO1999063943A2 (en) * 1998-06-12 1999-12-16 Craig Anthony Cooney Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring
RU2275041C2 (ru) 1999-04-29 2006-04-27 Сосьете Де Продюи Нестле С.А. Состав молочной смеси, способ его получения и молочная смесь, содержащая его (варианты)
KR20080009075A (ko) * 2005-03-10 2008-01-24 씰 파마, 인크. 영양 제제
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula

Also Published As

Publication number Publication date
MX2022014682A (es) 2023-01-11
BR112018011404A2 (pt) 2018-12-04
CN108367009A (zh) 2018-08-03
EP3984533A2 (en) 2022-04-20
EP3436015A2 (en) 2019-02-06
CA3004046A1 (en) 2017-10-05
CN118976042A (zh) 2024-11-19
CA3240258A1 (en) 2017-10-05
CA3015434A1 (en) 2017-10-05
PH12018501830A1 (en) 2019-05-15
SG11201806547SA (en) 2018-10-30
EP3984533A3 (en) 2022-09-07
WO2017167420A1 (en) 2017-10-05
SG11201803025VA (en) 2018-05-30
CN108778279A (zh) 2018-11-09
BR112018068369A2 (pt) 2019-01-15
MX2018011334A (es) 2019-01-31
CN119679814A (zh) 2025-03-25
CA3015434C (en) 2024-09-17

Similar Documents

Publication Publication Date Title
MX2018008519A (es) Composiciones que comprenden vitaminas y su uso.
MX2018006291A (es) Composiciones y su uso.
CL2018003142A1 (es) Moduladores de la vía de estrés integrada
CL2020000422A1 (es) Composiciones de glp-1 y sus usos.
MX389700B (es) Derivados de pirazolopiridina como moduladores de cinasa 1 progenitora hematopoyetica (hpk1) y usos de los mismos para tratamiento de cancer.
MX2022012236A (es) Composiciones que comprenden colina y su uso.
MX2016004605A (es) Formulaciones de anticuerpos estables acuosas.
DOP2016000291A (es) Composiciones y métodos para modular la expresión del factor b del complemento
PH12018501027A1 (en) Compositions comprising fatty acids and their use
MX2024010721A (es) Formulaciones topicas que contienen ciclosporina y usos de las mismas.
BR112017000313A2 (pt) sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal
MX2017005243A (es) Reducción de la viscosidad de formulaciones farmacéuticas.
UY36224A (es) Compuestos tricíclicos de imidazo-pirimidinona
MX2020008107A (es) Moduladores del receptor nmda espiro-lactama y usos de los mismos.
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
MX2022012237A (es) Composiciones que comprenden fosfolipido y su uso.
MX2016015961A (es) Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas.
WO2017167898A3 (en) Compositions comprising vitamins and their use
CL2018001602A1 (es) Composición nutricional y fórmula infantil para promover la mielinización del cerebro
CL2018001604A1 (es) Composición nutricional y fórmula infantil para promover la mielinización del cerebro
CL2018001600A1 (es) Una composición nutricional sintética que comprende una vitamina para usar a fin de promover, apoyar u optimizar la mielinización de novo
CL2018001603A1 (es) Composición nutricional y fórmula infantil para promover la mielinización de novo
PH12018501029A1 (en) Compositions comprising choline and their use
AR104982A1 (es) Derivados de diarilo y arilheteroaril úrea como moduladores del receptor de la serotonina 5-ht₂a útiles para la profilaxis y el tratamiento del trastorno de la conducta del sueño por presencia de movimientos oculares rápidos (por sus siglas en inglés, rem)
PL413416A1 (pl) Emulsja kosmetyczna typu olej/woda